This study is led by Dr. Weiren Huang (Shenzhen Institute of Translational Medicine, the First Affiliated Hospital of Shenzhen University). ...
Considering the molecular subtype of muscle-invasive bladder cancer (MIBC) based on differences in tumor RNA expression can improve the ability ...
PLYMOUTH MEETING, PA — New research in the November 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests ...
A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN) ...
A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part ...
New York, NY (October 22, 2023) — A clinical trial co-led by Mount Sinai researchers is the first to show that ...
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—a non-profit alliance of leading cancer centers across the United States—has ...
PLYMOUTH MEETING, PA —Evelyn Handel Zapata, PharmD, BCPS, BCOP, Senior Director of Drugs & Biologics Programs at the National Comprehensive ...
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections ...
“Overall, our work revealed a strong positive correlation between BRD4 overexpression status and chemoresistance in ovarian cancer ” Credit: 2023 ...
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awakens dormant cancer cells and promotes cancer growth, according ...
(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, ...
(Singapore – 10:05 a.m. SGT--September 11, 2023) – Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival ...
- The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy in terms of median ...
Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to ...
PLYMOUTH MEETING, PA — New research in the August 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network evaluates ...
New York, NY (August 3, 2023)—Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the ...
Breast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likelihood ...
LOS ANGELES — Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United ...
CLEVELAND - Pancreatic cancer is one of the most difficult cancers to treat, being highly resistant to chemotherapy. However, there ...
